Quality of life effects of antithrombin III in sepsis survivors: results from the KyberSept trial [ISRCTN22931023]
Dale Rublee(CSL (United States)), Sigurd Knaub, Wolfgang Schramm(Ludwig-Maximilians-Universität München), Steven M. Opal(Brown University), Heinz-Otto Keinecke
Cited by 44
Related Papers
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
|JAMA|2016|28.1k
Surviving Sepsis Campaign
|Critical Care Medicine|2013|9.7k
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
|Intensive Care Medicine|2013|7.3k
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
|Critical Care Medicine|2003|6k
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
|Intensive Care Medicine|2003|2.9k